šŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden flag Sweden Ā· Delayed Price Ā· Currency is SEK
2.465
+0.025 (1.02%)
Nov 20, 2026, 5:25 PM CET

Elicera Therapeutics AB Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Elicera Therapeutics AB stock has an average price target of krĀ 7.30. The average 1-year stock price forecast is 196.15% higher than the current stock price, while the lowest is krĀ 6.50 (+163.69%) and the highest is krĀ 8.00 (+224.54%).

Price Target: krĀ 7.30 (+196.15%)
Analyst Consensus: n/a

Price Target

Chart
TargetLowAverageMedianHigh
PricekrĀ 6.50krĀ 7.30krĀ 7.40krĀ 8.00
Change+163.69%+196.15%+200.20%+224.54%

Analyst Ratings

There are currently no analyst ratings available for Elicera Therapeutics AB.

Recommendation Trends

RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy000000
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total000000

Financial Forecast

Revenue This Year
1.60M
from 10.86M
Decreased by -85.26%
Revenue Next Year
29.97M
from 1.60M
Increased by 1,772.92%
EPS This Year
-0.47
from -0.38
EPS Next Year
-0.51
from -0.47
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
587.001.28M11.23M7.13M10.86M1.60M
Revenue Growth
-217,987.39%777.23%-36.53%52.28%-85.26%
Operating Income
-13.12M-19.36M-17.10M-16.88M-17.94M-26.43M
Net Income
-13.12M-19.44M-16.40M-16.11M-17.41M-25.00M
EPS
-----0.38-0.47
Free Cash Flow
------25.00M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.

Revenue Forecast

Revenue202620272028
High3.3M
Avg1.6M
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-69.6%
Avg
-85.3%
Low
-100.0%

EPS Forecast

EPS202620272028
High-0.43
Avg-0.47
Low-0.50

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-